If Bayer executes on the acquisition of seed maker Monsanto, the company’s agriculture business will more than double, surpassing pharmaceuticals as the top revenue generator, but management said its commitment to pharma remains unchanged.
Bayer AG is pursuing an acquisition of seed manufacturer Monsanto Co. that would establish agriculture as the largest business unit within the diversified life sciences company, usurping pharmaceuticals...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Scrip for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?